| Saadeh B Al-jureidini, MD | |
|
1465 S Grand Blvd, St. Louis, MO 63104-1003 | |
| (314) 268-4101 | |
| (314) 577-5379 |
| Full Name | Saadeh B Al-jureidini |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Cardiology |
| Location | 1465 S Grand Blvd, St. Louis, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144326315 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0202X | Pediatrics - Pediatric Cardiology | R2E88 (Missouri) | Primary |
| 208000000X | Pediatrics | R2E88 (Missouri) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Saadeh B Al-jureidini, MD 3691 Rutger Ave, St. Louis, MO 63110-2515 Ph: (314) 977-6828 | Saadeh B Al-jureidini, MD 1465 S Grand Blvd, St. Louis, MO 63104-1003 Ph: (314) 268-4101 |
News Archive
Prior research has shown not getting enough sleep can impact your weight, but new BYU research finds the consistency of your bed time and wake time can also influence body fat.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
A new antiseptic handwash, based on a formula previously used only by surgeons and other clinicians, will soon be available to consumers and provides up to six hours of prolonged germ kill with repeated use.
The U.S. Environmental Protection Agency will continue validating its ToxCast screening tool by screening more than 100 drugs provided by Pfizer, GlaxoSmithKline, Sanofi-Aventis, and Merck. These drugs never entered the marketplace because they demonstrated different types and levels of toxicity when the pharmaceutical companies conducted the early stage clinical trials required by the Food and Drug Administration as part of the drug development process.
A short exposure to an alternating magnetic field might someday replace multiple surgeries and weeks of IV antibiotics as treatment for stubborn infections on artificial joints, new research suggests.
› Verified 5 days ago
Patrick Francis Durkin, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Childrens Place, 3rd Floor, Suite 3s34, St. Louis, MO 63110 Phone: 314-454-6006 | |
Donna R Halloran, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1465 S Grand Blvd, St. Louis, MO 63104 Phone: 314-268-4101 Fax: 314-577-5379 | |
Shulamit Menashe Portnoy, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1465 S Grand Blvd, St. Louis, MO 63104 Phone: 314-577-5609 Fax: 314-268-4028 | |
Felicia L. Harvey, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11642 West Florissant, St. Louis, MO 63033 Phone: 314-838-8220 Fax: 314-838-8091 | |
Mary S Heaney, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1465 S Grand Blvd, St. Louis, MO 63104 Phone: 314-268-4101 Fax: 314-577-5379 | |
Dr. Kristen M Mennemeier, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3009 N. Ballas Rd., Suite 257c, St. Louis, MO 63131 Phone: 314-569-2112 Fax: 314-569-1270 | |
Lauren Rhae Draper, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1465 S Grand Blvd, Department Of Pediatrics Division Of Heme/onc, St. Louis, MO 63104 Phone: 314-577-5638 Fax: 314-268-4081 |